Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (TandAb)
TypeName:
Business Offer
Country:
Afghanistan
Summary:
"Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (TandAb) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. https://www.creative-biolabs.com/bsab/symbolsearch-cd16%2520%2526%2520egfr.htm"